Literature DB >> 27703680

Prevalence and distribution pattern of nodal metastases in advanced ovarian cancer.

Cornelia Bachmann1, Robert Bachmann2, Bernhard Kraemer1, Sara Yvonne Brucker1, Anette Staebler3, Falko Fend3, Ralf Rothmund1, Diethelm Wallwiener1.   

Abstract

The objective of this study was to examine the relevance of pelvic and para-aortic lymph node involvement and the tumour characteristics affecting nodal metastases and survival in primary advanced ovarian cancer. A total of 130 consecutive patients were retrospectively investigated. All the patients received stage-related surgery with pelvic and para-aortic lymphadenectomy. The median follow-up was 53.5 months. The clinicopathological parameters and distribution pattern of nodal metastases were evaluated. Lymph node metastases were detectable in 74.62% of the cases. Overall, both pelvic and para-aortic nodes were affected in 35.9% of the patients, whereas 13.3% had metastases only in the pelvic and 13.3% only in the para-aortic lymph nodes. Histological grade 1/2 and 3, serous and endometrioid histology were independent predictors of nodal metastasis. Serous and endometrioid cancers have shown a predilection for metastasis to the pelvic lymph nodes alone, both to the pelvic and the para-aortic nodes, or the para-aortic nodes alone. Overall survival was significantly positively affected by serous histology with positive nodes (P=0.043). It is crucial to investigate the risk factors and metastatic patterns of such patients in a multicenter analysis to evaluate individual subgroups. Prospective studies are required to investigate the prognostic effect of lymphadenectomy in advanced ovarian cancer and its association with histology and distribution pattern of nodal metastasis.

Entities:  

Keywords:  advanced ovarian cancer; histology; lymphadenectomy; nodal involvement; tumour characteristics

Year:  2016        PMID: 27703680      PMCID: PMC5038892          DOI: 10.3892/mco.2016.982

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  19 in total

1.  The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer.

Authors:  Akiko Abe; Hiroyuki Furumoto; Minoru Irahara; Hiroyasu Ino; Masaharu Kamada; Osamu Naka; Masaru Sasaki; Toshiaki Kagawa; Osamu Okitsu; Norio Kushiki
Journal:  J Obstet Gynaecol Res       Date:  2010-10       Impact factor: 1.730

2.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Authors:  Jaime Prat
Journal:  Int J Gynaecol Obstet       Date:  2013-10-22       Impact factor: 3.561

3.  Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Angelo Maggioni; Neville Hacker; Fabio Landoni; Sven Ackermann; Elio Campagnutta; Karl Tamussino; Raimund Winter; Antonio Pellegrino; Stefano Greggi; Roberto Angioli; Natalina Manci; Giovanni Scambia; Tiziana Dell'Anna; Roldano Fossati; Irene Floriani; Rita S Rossi; Roberto Grassi; Giuseppe Favalli; Francesco Raspagliesi; Diana Giannarelli; Luca Martella; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

4.  Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.

Authors:  Giovanni D Aletti; Sean Dowdy; Karl C Podratz; William A Cliby
Journal:  Am J Obstet Gynecol       Date:  2006-12       Impact factor: 8.661

5.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).

Authors:  Andreas du Bois; Alexander Reuss; Eric Pujade-Lauraine; Philipp Harter; Isabelle Ray-Coquard; Jacobus Pfisterer
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

6.  Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.

Authors:  T Onda; H Yoshikawa; T Yasugi; M Mishima; S Nakagawa; M Yamada; K Matsumoto; Y Taketani
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

7.  Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).

Authors:  Pauline Wimberger; Nils Lehmann; Rainer Kimmig; Alexander Burges; Werner Meier; Andreas Du Bois
Journal:  Gynecol Oncol       Date:  2007-03-29       Impact factor: 5.482

8.  Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease.

Authors:  C Scarabelli; A Gallo; M C Visentin; V Canzonieri; A Carbone; A Zarrelli
Journal:  Int J Gynecol Cancer       Date:  1997-01       Impact factor: 3.437

9.  Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer.

Authors:  Suk-Joon Chang; Robert E Bristow; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

10.  Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture.

Authors:  Dong Hoon Suh; Tae Hun Kim; Jae-Weon Kim; Sun Young Kim; Hee Seung Kim; Taek Sang Lee; Hyun Hoon Chung; Yong-Beom Kim; Noh Hyun Park; Yong Sang Song
Journal:  J Gynecol Oncol       Date:  2013-10-02       Impact factor: 4.401

View more
  2 in total

1.  The passive biomechanics of human pelvic collecting lymphatic vessels.

Authors:  Dimitrios Athanasiou; Lowell T Edgar; Mohammad Jafarnejad; Katherine Nixon; Delfim Duarte; Edwin D Hawkins; Samira Jamalian; Paula Cunnea; Cristina Lo Celso; Shunichi Kobayashi; Christina Fotopoulou; James E Moore
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

2.  Inflammatory state of lymphatic vessels and miRNA profiles associated with relapse in ovarian cancer patients.

Authors:  Sarah C Johnson; Sanjukta Chakraborty; Anastasios Drosou; Paula Cunnea; Dimitrios Tzovaras; Katherine Nixon; David C Zawieja; Mariappan Muthuchamy; Christina Fotopoulou; James E Moore
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.